United States · FDA National Drug Code directory
Naprelan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24979-249_1ae3fb8f-0340-45e5-9f71-fe284c0a6037
- Product NDC
- 24979-249
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Naproxen Sodium
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251231
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-249-01) · 24979-249-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →